Key facts today
AstraZeneca rejoined PhRMA after two years, aiming to tackle potential tariffs and enhance its U.S. presence through investments in research, development, and manufacturing.
AstraZeneca and 30+ pharma firms urged the EU to reassess medicine pricing, emphasizing the need for higher prices in Europe to foster innovation and remain competitive with the U.S.
A study in Nature Communications shows older cancer patients respond well to immune checkpoint inhibitors, including AstraZeneca's, indicating potential for improved treatments for this age group.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.044 CHF
6.26 B CHF
48.08 B CHF
1.47 B
About ASTRAZENECA PLC ORD USD0.25
Sector
Industry
CEO
Pascal Soriot
Website
Headquarters
Cambridge
Founded
1992
ISIN
GB0009895292
FIGI
BBG007FJNM20
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Supply and Demand Trading Made Simple With Astrazeneca StockIn the ever-evolving world of stock trading, where news headlines can shift markets in a heartbeat, savvy investors often turn to the age-old principles of supply and demand to find clarity. Enter AstraZeneca stock (NASDAQ: AZN) — a biopharmaceutical titan that has played a pivotal role in global he
Astrazeneca potentially to $88AstraZeneca’s share price has been hovering around a long-term trend line established since 2017. Historically, each time the price has tested this trend line, it has rebounded sharply, suggesting strong investor confidence.
From 2017 to 2023, the company’s financial performance has been notably ro
BULLISH ON AZNAstraZeneca's Q3 2024 earnings exceeded expectations, with a revenue increase of 18%, signaling healthy demand for its products, especially in oncology and rare diseases.
Technicals - Key Indicators:
RSI (Relative Strength Index): Currently at 41.08, indicating strong bullish momentum but not ye
Astrazeneca (Wait for correction to complete)Hello,
To demonstrate how we can leverage TradingView for informed investment decisions, let’s analyze AstraZeneca as our example today. I will follow a structured approach and provide an investment recommendation based on both fundamental and technical insights.
Understanding the Business
Befor
AZN eyes on $71: Double Fib support that could launch a leg up AZN daily chart shows a significant pullback.
Currently testing a double Fib (Genesis+Covid).
Long entry option with a tight SL just below fibs.
$ 70.95-71.01 is the tight support of interest.
$ 80.48-81.11 would be an optimistic target.
===========================================
.
AstraZeneca - GBP | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Active Sessions on Relevant Range & Elemented Probabilities;
* Asian(Ranging) - London(Upwards) - NYC(Downwards)
* Weekend Crypto Session
Trend | Time Frame Conductive | Weekly Time Frame
- General Tr
AZN Astrazeneca plc ADRI’ve been closely monitoring AZN, which has been trading on the upside for a while now. Given the recent momentum, it appears to be approaching a point where a downward move could be imminent. I believe the stock might be ready to take a dip, presenting a potential opportunity for a downside play.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ZEG is featured.
Related stocks
Frequently Asked Questions
The current price of ZEG is 114.270 CHF — it has increased by 3.27% in the past 24 hours. Watch ASTRAZENECA PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ASTRAZENECA PLC stocks are traded under the ticker ZEG.
ZEG stock has risen by 3.99% compared to the previous week, the month change is a −21.46% fall, over the last year ASTRAZENECA PLC has showed a −9.24% decrease.
We've gathered analysts' opinions on ASTRAZENECA PLC future price: according to them, ZEG price has a max estimate of 185.98 CHF and a min estimate of 112.52 CHF. Watch ZEG chart and read a more detailed ASTRAZENECA PLC stock forecast: see what analysts think of ASTRAZENECA PLC and suggest that you do with its stocks.
ZEG stock is 3.23% volatile and has beta coefficient of 0.92. Track ASTRAZENECA PLC stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA PLC there?
Today ASTRAZENECA PLC has the market capitalization of 172.33 B, it has increased by 2.95% over the last week.
Yes, you can track ASTRAZENECA PLC financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA PLC is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
ZEG earnings for the last quarter are 1.90 CHF per share, whereas the estimation was 1.88 CHF resulting in a 0.96% surprise. The estimated earnings for the next quarter are 1.97 CHF per share. See more details about ASTRAZENECA PLC earnings.
ASTRAZENECA PLC revenue for the last quarter amounts to 13.52 B CHF, despite the estimated figure of 12.92 B CHF. In the next quarter, revenue is expected to reach 12.24 B CHF.
ZEG net income for the last quarter is 1.33 B CHF, while the quarter before that showed 1.25 B CHF of net income which accounts for 6.77% change. Track more ASTRAZENECA PLC financial stats to get the full picture.
ASTRAZENECA PLC dividend yield was 2.35% in 2024, and payout ratio reached 69.15%. The year before the numbers were 2.15% and 73.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 23, 2025, the company has 94.3 K employees. See our rating of the largest employees — is ASTRAZENECA PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA PLC EBITDA is 15.64 B CHF, and current EBITDA margin is 33.02%. See more stats in ASTRAZENECA PLC financial statements.
Like other stocks, ZEG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA PLC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA PLC stock shows the strong sell signal. See more of ASTRAZENECA PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.